V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007263 | 310004423 | 1.76 | null | Curative (C) | null | 2017-03-07 | LEAM | null | N | 310017300 | LEAM |
| 310007264 | 310004423 | 1.58 | 65.8 | Curative (C) | 2013-10-13 | 2013-10-18 | BEAM | 2 | N | 310017300 | BEAM |
| 310007265 | 310004424 | 1.76 | null | Palliative (P) | 2015-06-17 | 2015-07-06 | BEAM | N | N | 310017311 | BEAM |
| 310007266 | 310004425 | 1.57 | 97.1 | Disease modification (D) | null | 2017-08-15 | IVE | null | null | 310017325 | IVE |
| 310007267 | 310004426 | 0 | 13.3 | Palliative (P) | null | 2017-03-19 | NB HRNBL-1 TVD | N | N | 310017325 | NOT MATCHED |
| 310007268 | 310004426 | null | 68 | Palliative (P) | null | 2017-12-28 | PEMBROLIZUMAB | N | N | 310017325 | PEMBROLIZUMAB |
| 310007269 | 310004426 | 1.6 | 76 | Curative (C) | 2015-10-30 | 2015-10-30 | LEAM | N | N | 310017325 | LEAM |
| 310007270 | 310004428 | 1.63 | 73.7 | Disease modification (D) | 2016-05-18 | 2016-05-18 | LEAM | N | N | 310017341 | LEAM |
| 310007271 | 310004430 | 1.6 | 85 | Palliative (P) | 2019-02-27 | 2019-03-10 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310017347 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007272 | 310004431 | null | 51 | Curative (C) | 2017-06-23 | 2017-06-25 | IVE | 02 | N | 310017348 | IVE |
| 310007273 | 310009695 | 1.6 | 60.85 | Neo-adjuvant (N) | null | 2018-04-11 | CISPLATIN + GEMCITABINE | N | N | 310017348 | CISPLATIN + GEMCITABINE |
| 310007274 | 310004432 | 1.77 | 59.8 | Curative (C) | 2016-08-14 | 2016-11-14 | IVE | N | N | 310017356 | IVE |
| 310007275 | 310004433 | 1.66 | 53.9 | Adjuvant (A) | 2017-02-17 | 2017-02-17 | LEAM | 02 | null | 310017357 | LEAM |
| 310007276 | 310004433 | 1.63 | 24.9 | Palliative (P) | 2014-06-25 | 2014-07-06 | PEMBROLIZUMAB | N | N | 310017357 | PEMBROLIZUMAB |
| 310007277 | 310004434 | 1.71 | 74.6 | null | 2014-06-03 | 2014-06-18 | GEM-P | 02 | N | 310017365 | GEMCITABINE + PACLITAXEL |
| 310007278 | 310004434 | 1.59 | 60.1 | Palliative (P) | 2014-11-20 | 2014-12-01 | Carboplatin + Liposomal Doxorubicin | N | null | 310017365 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007279 | 310004435 | 1.58 | 56.6 | Curative (C) | 2017-05-28 | 2017-06-04 | IVE | 02 | null | 310017366 | IVE |
| 310007280 | 310009698 | null | 100.6 | Curative (C) | 2013-10-31 | 2013-11-22 | Gemcitabine weekly | 02 | N | 310017373 | GEMCITABINE |
| 310007281 | 310009698 | 1.63 | 68.5 | Palliative (P) | 2016-12-04 | 2016-12-21 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 310017373 | GEMCITABINE |
| 310007282 | 310011541 | 1.8 | null | null | 2014-11-17 | 2014-12-06 | Brentuximab | 02 | N | 310017383 | BRENTUXIMAB |
| 310007283 | 310004437 | 1.77 | 81.7 | null | 2017-06-13 | 2017-06-13 | Brentuximab | N | N | 310017385 | BRENTUXIMAB |
| 310007284 | 310004438 | 1.5 | 47 | Palliative (P) | 2018-02-28 | 2018-03-07 | Carboplatin + Liposomal Doxorubicin | N | N | 310017399 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007288 | 310004441 | 1.85 | 60.3 | Curative (C) | 2016-09-13 | 2016-09-13 | Brentuximab | 02 | N | 310017427 | BRENTUXIMAB |
| 310007289 | 310004442 | 1.73 | 81.7 | Palliative (P) | 2018-04-14 | 2018-04-22 | PEMBROLIZUMAB | N | N | 310017429 | PEMBROLIZUMAB |
| 310007290 | 310004443 | null | null | Palliative (P) | null | 2015-04-08 | Brentuximab Vedotin | 02 | N | 310017432 | BRENTUXIMAB |
| 310007291 | 310009701 | 1.75 | 76 | Curative (C) | 2016-09-25 | 2016-11-10 | Brentuximab | Y | null | 310017439 | BRENTUXIMAB |
| 310007292 | 310010677 | 1.64 | 54 | Palliative (P) | 2015-10-08 | 2015-10-08 | Carboplatin + Liposomal Doxorubicin | Y | N | 310017452 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007293 | 310004446 | 1.55 | 85.7 | Palliative (P) | 2016-06-28 | 2016-07-08 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310017474 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007294 | 310004449 | 1.71 | 67.9 | Palliative (P) | 2015-01-21 | 2015-02-18 | PEMBROLIZUMAB | N | N | 310017481 | PEMBROLIZUMAB |
| 310007295 | 310004449 | 1.58 | 8.2 | Palliative (P) | 2017-05-26 | 2017-05-27 | Brentuximab Vedotin | 2 | N | 310017481 | BRENTUXIMAB |
| 310007297 | 310004452 | 1.61 | 73.65 | Palliative (P) | 2015-09-25 | 2016-01-17 | GEM-P | N | N | 310017503 | GEMCITABINE + PACLITAXEL |
| 310007298 | 310004453 | 1.6 | 55.9 | Palliative (P) | 2014-01-26 | 2014-01-26 | PEMBROLIZUMAB | 02 | N | 310017506 | PEMBROLIZUMAB |
| 310007299 | 310004454 | 1.65 | 63.7 | Palliative (P) | 2017-08-30 | 2017-09-13 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310017508 | CISPLATIN + GEMCITABINE |
| 310007300 | 310004454 | 1.65 | 84.4 | Neo-adjuvant (N) | null | 2014-06-02 | CISPLATIN + GEMCITABINE | N | null | 310017508 | CISPLATIN + GEMCITABINE |
| 310007301 | 310004455 | 1.65 | 85 | Palliative (P) | 2017-08-23 | 2017-08-24 | PEMBROLIZUMAB | N | N | 310017513 | PEMBROLIZUMAB |
| 310007302 | 310004458 | 1.7 | 73.5 | Palliative (P) | 2013-09-09 | 2013-09-09 | LEAM | N | N | 310017514 | LEAM |
| 310007303 | 310004459 | 1.71 | null | Curative (C) | 2013-10-15 | 2013-10-15 | LEAM | N | N | 310017518 | LEAM |
| 310007304 | 310004460 | 1.68 | 55.5 | Curative (C) | 2016-01-30 | 2016-01-31 | LEAM | null | null | 310017518 | LEAM |
| 310007305 | 310009705 | 1.6 | 80 | Palliative (P) | null | 2014-12-23 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 310017523 | CISPLATIN + GEMCITABINE |
| 310007306 | 310009705 | 1.64 | 68.9 | Palliative (P) | 2016-06-08 | 2016-06-08 | PEMBROLIZUMAB | 2 | N | 310017523 | PEMBROLIZUMAB |
| 310007307 | 310009705 | null | 70.1 | Curative (C) | 2016-04-02 | 2016-04-02 | BEAM | 02 | null | 310017523 | BEAM |
| 310007308 | 310011542 | 1.8 | 8 | Curative (C) | 2018-02-26 | 2018-03-01 | BEAM | 2 | N | 310017544 | BEAM |
| 310007309 | 310011725 | 1.84 | 18.5 | Palliative (P) | 2016-12-22 | 2016-12-23 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 310017546 | GEMCITABINE |
| 310007310 | 310004461 | 1.75 | 75.9 | Curative (C) | 2017-11-08 | 2018-03-28 | BEAM | N | N | 310017548 | BEAM |
| 310007311 | 310004462 | null | 13 | Palliative (P) | 2018-12-16 | 2018-12-30 | PEMBROLIZUMAB | N | N | 310017552 | PEMBROLIZUMAB |
| 310007312 | 310004462 | 1.5 | null | Curative (C) | 2017-01-15 | 2017-01-15 | IVE | 02 | N | 310017552 | IVE |
| 310007313 | 310004463 | 1.68 | 85 | Palliative (P) | 2019-06-12 | 2019-06-15 | PEMBROLIZUMAB | N | N | 310017565 | PEMBROLIZUMAB |
| 310007314 | 310004463 | 1.65 | 51.1 | Curative (C) | 2013-12-10 | 2013-12-11 | BEAM | N | N | 310017565 | BEAM |
| 310007315 | 310004464 | 1.5 | 76 | Palliative (P) | 2017-06-07 | 2018-01-02 | Carboplatin + Liposomal Doxorubicin | N | N | 310017573 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007316 | 310004464 | 1.55 | 19.05 | Palliative (P) | 2017-10-16 | 2017-10-22 | Carboplatin + Liposomal Doxorubicin | N | N | 310017573 | CARBOPLATIN + LIPOSOMAL DOX |